Clinical Trial 40209

share

Garden Grove, CA 92845


Study Summary:

A Phase 2a, Randomized, Double-Blind, Placebo-Controlled,
Parallel-group Study to Assess the Safety and Efficacy of
ASP4345 as Add-on Treatment for Cognitive Impairment
in Subjects with Schizophrenia on Stable Doses
of Antipsychotic Medication


Qualified Participants Must:

• Subject is a male or female subject between 18 to 55 years of age


Qualified Participants May Receive:

Compensation for time and travel 


Study is Available At:

CNS Network
12772 Valley View Ave, Suite 3
Garden Grove, CA 92845
View Clinic Location

 


If you or someone you care for is interested in participating in this clinical trial and lives within 50 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.